Dr Reddys Laboratories (RDY) Net Equity Issued and Repurchased (2009 - 2019)

Dr Reddys Laboratories has reported Net Equity Issued and Repurchased for 8 years, with the latest figure at $42101.2 in Q4 2019.

• On a quarterly basis, Net Equity Issued and Repurchased rose 204.02% year-over-year to $42101.2 in Q4 2019; TTM through Dec 2019 was $27925.7, a 4.99% decrease from a year earlier, with the FY2018 full-year figure at $15544.0, up 4.19% from the prior year.
• Net Equity Issued and Repurchased was $42101.2 for Q4 2019 at Dr Reddys Laboratories, up from -$14175.5 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $64255.3 in Q1 2015, with the low at -$14175.5 in Q1 2019.
• Average Net Equity Issued and Repurchased over 3 years is $24314.6, with a median of $15544.0 recorded in 2018.
• The sharpest annual moves came in 2015 and 2019: Net Equity Issued and Repurchased jumped 296.5% in 2015, then plunged 191.2% in 2019.
• Over 3 years, Net Equity Issued and Repurchased stood at $64255.3 in 2015, then plunged by 78.45% to $13848.0 in 2018, then surged by 204.02% to $42101.2 in 2019.
• The last three Net Equity Issued and Repurchased figures came in at $42101.2 (Q4 2019), -$14175.5 (Q1 2019), and $13848.0 (Q4 2018), per Business Quant data.